• 1. Exciting clusters, what does off-resonance actually mean??
  Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 5. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735

Introduction to 5-Bromo-6-methyl-1H-benzodimidazole (CAS No. 116106-16-2)

5-Bromo-6-methyl-1H-benzodimidazole, with the CAS number 116106-16-2, is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, which include a bromine atom and a methyl group attached to a benzodimidazole core. These structural elements contribute to its potential biological activities and make it an interesting candidate for various applications.

The benzodimidazole scaffold is a well-known heterocyclic structure that has been extensively studied for its diverse biological properties, including antiviral, antibacterial, and anticancer activities. The presence of the bromine and methyl substituents in 5-Bromo-6-methyl-1H-benzodimidazole further modulates its pharmacological profile, making it a valuable lead compound for drug discovery.

Recent research has highlighted the potential of 5-Bromo-6-methyl-1H-benzodimidazole in various therapeutic areas. For instance, studies have shown that this compound exhibits potent antiviral activity against several RNA viruses, including influenza and coronaviruses. The mechanism of action is believed to involve the inhibition of viral replication through the disruption of key viral enzymes or pathways.

In addition to its antiviral properties, 5-Bromo-6-methyl-1H-benzodimidazole has also been investigated for its anticancer potential. Preclinical studies have demonstrated that this compound can selectively inhibit the growth of cancer cells while sparing normal cells. The selective cytotoxicity is attributed to its ability to target specific cellular pathways that are often dysregulated in cancer cells, such as the PI3K/AKT/mTOR pathway.

The structural flexibility of 5-Bromo-6-methyl-1H-benzodimidazole allows for the synthesis of various derivatives through chemical modifications. These derivatives can be tailored to enhance specific biological activities or improve pharmacokinetic properties, such as solubility and bioavailability. For example, the introduction of additional functional groups or changes in the position of existing substituents can significantly impact the compound's binding affinity to target proteins or receptors.

The synthesis of 5-Bromo-6-methyl-1H-benzodimidazole typically involves multi-step reactions, starting from readily available starting materials. Common synthetic routes include the condensation of appropriate arylamines with aldehydes or ketones, followed by cyclization and substitution reactions to introduce the desired functional groups. Advances in synthetic methodologies have made it possible to produce this compound on a larger scale, facilitating its use in high-throughput screening and other large-scale applications.

In terms of safety and toxicity, preliminary studies suggest that 5-Bromo-6-methyl-1H-benzodimidazole exhibits low toxicity at therapeutic concentrations. However, further toxicological evaluations are necessary to ensure its safety for clinical use. These evaluations typically involve in vitro and in vivo assays to assess potential adverse effects on various organ systems.

The potential applications of 5-Bromo-6-methyl-1H-benzodimidazole extend beyond medicinal chemistry. In materials science, this compound has been explored as a building block for the synthesis of functional materials with unique optical and electronic properties. For example, derivatives of this compound have been used in the development of organic semiconductors and luminescent materials for use in organic light-emitting diodes (OLEDs) and other optoelectronic devices.

In conclusion, 5-Bromo-6-methyl-1H-benzodimidazole (CAS No. 116106-16-2) is a promising compound with a wide range of potential applications in both medicinal chemistry and materials science. Its unique structural features and biological activities make it an attractive candidate for further research and development. As ongoing studies continue to uncover new insights into its properties and mechanisms of action, it is likely that this compound will play an increasingly important role in various scientific and technological fields.

• 255064-10-9(5-Bromo-7-methyl-1H-benzodimidazole)
• 1782183-93-0(6-Bromo-5-formyl-1H-benzimidazole)
• 1804153-06-7(2-Amino-5-bromo-6-bromomethyl-1H-benzimidazole)
• 646504-80-5(6-Bromo-7-methylquinoxaline)
• 4887-88-1(5-Bromo-1H-benzimidazole)
• 1126824-09-6(4-Bromo-6-methyl-3H-1,3-benzodiazole)
• 1803894-87-2(6-Bromo-5-difluoromethyl-1H-benzimidazole)
• 1803894-98-5(6-Bromo-5-hydroxymethyl-1H-benzimidazole)
• 1360963-03-6(4-bromo-5-methyl-1H-1,3-benzodiazole)
• 952511-48-7(5-bromo-4-methyl-1H-benzodimidazole)